Medtronic announces FDA approval of new cervical disc offering for two-level procedures
Medtronic announced it has received FDA approval of the Prestige LP cervical disc for treatment of cervical disc disease that causes nerve or spinal cord compression at two adjacent levels between C3-C7.
According to a company press release, the Prestige LP is designed to allow for neck motion at the operated levels. It is also reportedly safe and effective for both one- and two-level surgeries and, according to the release, is the first artificial disc on the U.S. market that has been proven to be statistically superior in overall success for one-level and two-level surgeries.
“Medtronic is committed to elevating spine care by combining innovative new technologies with clinical evidence,” Doug King, senior vice president and president of Medtronic’s Spine Division, which is part of the Restorative Therapies Group at Medtronic, said in the release. “The Prestige LP Disc is a superior alternative to [anterior cervical discectomy and fusion] ACDF and an important motion-preserving option for physicians treating certain patients suffering from two-level cervical disc disease.”
According to the release, the Prestige LP disc has a ball-and-trough design and can move in various ranges of motion, such as bending, rotation and translation.